These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
200 related articles for article (PubMed ID: 11739371)
21. Glycogen and related polysaccharides inhibit the laforin dual-specificity protein phosphatase. Wang W; Roach PJ Biochem Biophys Res Commun; 2004 Dec; 325(3):726-30. PubMed ID: 15541350 [TBL] [Abstract][Full Text] [Related]
22. A novel EPM2A mutation yields a slow progression form of Lafora disease. Garcia-Gimeno MA; Rodilla-Ramirez PN; Viana R; Salas-Puig X; Brewer MK; Gentry MS; Sanz P Epilepsy Res; 2018 Sep; 145():169-177. PubMed ID: 30041081 [TBL] [Abstract][Full Text] [Related]
23. Alternative splicing modulates subcellular localization of laforin. Ganesh S; Suzuki T; Yamakawa K Biochem Biophys Res Commun; 2002 Mar; 291(5):1134-7. PubMed ID: 11883934 [TBL] [Abstract][Full Text] [Related]
24. Lafora disease in the Indian population: EPM2A and NHLRC1 gene mutations and their impact on subcellular localization of laforin and malin. Singh S; Satishchandra P; Shankar SK; Ganesh S Hum Mutat; 2008 Jun; 29(6):E1-12. PubMed ID: 18311786 [TBL] [Abstract][Full Text] [Related]
25. Regulation of glycogen synthesis by the laforin-malin complex is modulated by the AMP-activated protein kinase pathway. Solaz-Fuster MC; Gimeno-Alcañiz JV; Ros S; Fernandez-Sanchez ME; Garcia-Fojeda B; Criado Garcia O; Vilchez D; Dominguez J; Garcia-Rocha M; Sanchez-Piris M; Aguado C; Knecht E; Serratosa J; Guinovart JJ; Sanz P; Rodriguez de Córdoba S Hum Mol Genet; 2008 Mar; 17(5):667-78. PubMed ID: 18029386 [TBL] [Abstract][Full Text] [Related]
26. Structural mechanism of laforin function in glycogen dephosphorylation and lafora disease. Raththagala M; Brewer MK; Parker MW; Sherwood AR; Wong BK; Hsu S; Bridges TM; Paasch BC; Hellman LM; Husodo S; Meekins DA; Taylor AO; Turner BD; Auger KD; Dukhande VV; Chakravarthy S; Sanz P; Woods VL; Li S; Vander Kooi CW; Gentry MS Mol Cell; 2015 Jan; 57(2):261-72. PubMed ID: 25544560 [TBL] [Abstract][Full Text] [Related]
27. Dimerization of Laforin is required for its optimal phosphatase activity, regulation of GSK3beta phosphorylation, and Wnt signaling. Liu Y; Wang Y; Wu C; Liu Y; Zheng P J Biol Chem; 2006 Nov; 281(46):34768-74. PubMed ID: 16971387 [TBL] [Abstract][Full Text] [Related]
28. Assessing the Biological Activity of the Glucan Phosphatase Laforin. Romá-Mateo C; Raththagala M; Gentry MS; Sanz P Methods Mol Biol; 2016; 1447():107-19. PubMed ID: 27514803 [TBL] [Abstract][Full Text] [Related]
29. Laforin is a cell membrane and endoplasmic reticulum-associated protein tyrosine phosphatase. Minassian BA; Andrade DM; Ianzano L; Young EJ; Chan E; Ackerley CA; Scherer SW Ann Neurol; 2001 Feb; 49(2):271-5. PubMed ID: 11220751 [TBL] [Abstract][Full Text] [Related]
30. Laforin in autophagy: a possible link between carbohydrate and protein in Lafora disease? Puri R; Ganesh S Autophagy; 2010 Nov; 6(8):1229-31. PubMed ID: 20818153 [TBL] [Abstract][Full Text] [Related]
31. Laforin, a dual-specificity phosphatase involved in Lafora disease, is phosphorylated at Ser25 by AMP-activated protein kinase. Romá-Mateo C; Solaz-Fuster Mdel C; Gimeno-Alcañiz JV; Dukhande VV; Donderis J; Worby CA; Marina A; Criado O; Koller A; Rodriguez De Cordoba S; Gentry MS; Sanz P Biochem J; 2011 Oct; 439(2):265-75. PubMed ID: 21728993 [TBL] [Abstract][Full Text] [Related]
32. Lafora progressive myoclonus epilepsy: recent insights into cell degeneration. Spuch C; Ortolano S; Navarro C Recent Pat Endocr Metab Immune Drug Discov; 2012 May; 6(2):99-107. PubMed ID: 22369717 [TBL] [Abstract][Full Text] [Related]
34. Expression, purification and characterization of soluble red rooster laforin as a fusion protein in Escherichia coli. Brewer MK; Husodo S; Dukhande VV; Johnson MB; Gentry MS BMC Biochem; 2014 Apr; 15():8. PubMed ID: 24690255 [TBL] [Abstract][Full Text] [Related]